606 results on '"Abol‐Enein, Hassan"'
Search Results
2. Association of interleukin6 rs1800796 gene polymorphism and serum level with bladder cancer in Egyptian population
3. Effect of Heavy Metals on Non-muscle Invasive Bladder Cancer and Its Relation to TLR Signaling Pathway
4. Prospective Assessment of Multiple Urinary Biomarkers to Diagnose Recurrence and Progression in Patients with Non‑muscle‑Invasive Bladder Cancer
5. Metabolic stone workup abnormalities are not as important as stone culture in patients with recurrent stones undergoing percutaneous nephrolithotomy
6. The impact of chemotherapy-naïve open radical cystectomy delay and perioperative transfusion on the recurrence-free survival: A perioperative parameters-based nomogram
7. Development of a Pocket Nomogram to Predict Cancer and Disease Specific Survival After Radical Cystectomy For Bladder Cancer: The CRAB Nomogram
8. Identification of Different miRNAs and Their Relevant miRNA Targeted Genes Involved in Sister Chromatid Cohesion and Segregation (SCCS)/chromatin Remodeling Pathway on T1G3 Urothelial Carcinoma (UC) Response to BCG Immunotherapy
9. Oncologic Outcomes of Squamous Cell Carcinoma Versus Urothelial Carcinoma With Squamous Differentiation After Radical Cystectomy for Bladder Carcinoma
10. Surgical cystectomy training using human cadavers embalmed using Thiel's method: a pilot study.
11. Gene expression and oxidative stress markers profile associated with toxic metals in patients with renal cell carcinoma
12. MP22-16 FUNCTIONAL OUTCOMES OF ORTHOTOPIC ILEAL NEOBLADDER MORE THAN A DECADE OF FOLLOW UP
13. MP21-18 ACCURACY OF SHEAR WAVE ELASTOGRAPHY IN THE EVALUATION OF PEDIATRIC RENAL SCARRING AFTER MINIMALLY INVASIVE INTERVENTION FOR UNILATERAL STONE DISEASE
14. Association between hepatitis C virus genotype 4 and renal cell carcinoma: Molecular and virological studies
15. Validation of the COBRA nomogram for the prediction of cancer specific survival in patients treated with radical cystectomy for bladder cancer: An international wide cohort study
16. Rs-10889677 variant in interleukin-23 receptor may contribute to creating an inflammatory milieu more susceptible to bladder tumourigenesis: report and meta-analysis
17. Correlation between blood levels of cadmium and lead and the expression of microRNA-21 in Egyptian bladder cancer patients
18. Does the Presence of Heavy Metals Influence the Gene Expression and Oxidative Stress in Bladder Cancer?
19. Evaluation of serum fatty acid binding protein-4 (FABP-4) as a novel biomarker to predict biopsy outcomes in prostate biopsy naïve patients
20. ERCC1 rs11615 Single Nucleotide Polymorphism in Bladder Cancer Patients and Safety Outcomes of Cisplatin-Based Chemotherapy.
21. Value of Immunological Biomarkers in Early Prediction of Bacillus Calmette-Guerin Failure in High-Risk Non-muscle-invasive Bladder Cancer
22. Novel urine-based DNA methylation biomarkers for urothelial bladder carcinoma detection in patients with hematuria.
23. Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort
24. PD13-10 THE IMPACT OF PURIFIED PROTEIN DERIVATIVE PRIOR TO INTRAVESICAL BACILLUS CALMETTE-GUÉRIN FOR THE TREATMENT OF PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER: A CONTROLLED CLINICAL TRIAL
25. MP32-03 INCIDENCE AND OUTCOMES OF OCCULT LYMPH NODE METASTASIS IN CLINICALLY CT2-4A NO BLADDER CANCER AT RADICAL CYSTECTOMY WITH OR WITHOUT NEOADJUVANT CHEMOTHERAPY
26. MP08-19 NOVEL URINE-BASED DNA METHYLATION BIOMARKERS FOR UROTHELIAL BLADDER CARCINOMA DETECTION IN PATIENTS WITH HEMATURIA
27. Prospective Validation of Clinical Usefulness of a Novel mRNA-based Urine Test (Xpert® Bladder Cancer Monitor) for surveillance in Non Muscle Invasive Bladder Cancer
28. Reply by authors to comment on “Evaluation of serum fatty acid binding protein-4 (FABP-4) as a novel biomarker to predict biopsy outcomes in prostate biopsy naive patients”
29. Utility of Biomarkers in the Prediction of Oncologic Outcome after Radical Cystectomy for Squamous Cell Carcinoma
30. Idiopathic retroperitoneal fibrosis: clinical features and long-term renal function outcome
31. Is chronic alkali therapy in orthotopic ileal neobladders necessary? A prospective controlled study
32. Nontransitional Carcinoma of the Bladder
33. The impact of chemotherapy-naïve open radical cystectomy delay and perioperative transfusion on the recurrence-free survival: A perioperative parameters-based nomogram
34. Identification of Epigenetic Interactions between miRNA and Gene Expression as Potential Prognostic Markers in Bladder Cancer
35. Rare findings in Cystoscopy
36. Comparison of urinary telomerase, CD44, and NMP22 assays for detection of bladder squamous cell carcinoma
37. Investigation of Virulence Genes of the Predominant Bacteria Associated with Renal Stones and their Correlation with Postoperative Septic Complications
38. Predictors and survival benefit of achieving pentafecta in a contemporary series of open radical cystectomy
39. Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy
40. Serous-lined Unidirectional Valve for Construction of Continent Cutaneous Urinary Reservoir: The Test of Time
41. Does the afferent tubular segment in an orthotopic bladder substitution compromise ureteric antireflux properties? An experimental study in dogs
42. Ileal Urinary Reservoir in Pediatric Population: Objective Assessment of Long-term Sequelae With Time-to-event Analysis
43. MP56-07 PREDICTORS OF RESPONSE FOLLOWING NEOADJUVANT CISPLATIN BASED CHEMOTHERAPY FOR MUSCLE INVASIVE UROTHELIAL BLADDER CANCER USING MOLECULAR PROFILE
44. Kidney preservation protocol for management of emphysematous pyelonephritis: Treatment modalities and follow-up
45. Recoverability of renal function after relief of chronic partial unilateral ureteric obstruction: The effect of an angiotensin-converting enzyme inhibitor (enalapril)
46. Expression of cell cycle–related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder
47. Gene expression and oxidative stress markers profile associated with toxic metals in patients with renal cell carcinoma
48. SINGLE LYMPH NODE MALIGNANT INVOLVEMENT POST RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER: CLINICAL OUTCOMES AND PROGNOSTIC IMPLICATIONS: PD33-12
49. PATHOLOGICAL CHARACTERISTICS AND PROGNOSTIC INDICATORS OF DIFFERENT HISTOPATHOLOGICAL TYPES FOLLOWING RADICAL CYSTECTOMY: A LARGE COHORT WITH LONG-TERM FOLLOW-UP: PD33-04
50. DEVELOPMENT, VALIDATION & CLINICAL APPLICATION OF AN INTRA-OPERATIVE ASSESSMENT OF COMPLETION & APPROPRIATENESS OF LND AFTER RADICAL CYSTECTOMY: PELVIC LYMPHADENECTOMY APPROPRIATENESS & COMPLETION EVALUATION (PLACE): PD27-04
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.